Target intelligence / Profile preview

Excitatory glutamatergic synaptic transmission in spinal dorsal horn

Molecular classification
Ion channel, G protein-coupled receptor, Transporter
01

Overview

Excitatory glutamatergic synaptic transmission in the spinal dorsal horn is the primary physiological mechanism for the relay of nociceptive signals from the periphery to the central nervous system (StatPearls, 2023). This process involves the release of glutamate from primary afferent terminals and its subsequent activation of postsynaptic ionotropic receptors, including AMPA, NMDA, and kainate receptors, as well as metabotropic glutamate receptors (mGluRs) (PubMed, PMID: 29029618). Under conditions of chronic injury or inflammation, this pathway undergoes plastic changes known as central sensitization, which leads to an exaggerated response to painful stimuli (hyperalgesia) and pain from non-painful stimuli (allodynia) (Nature Reviews Neuroscience, 2011). Pharmacological targeting of this transmission involves the use of NMDA receptor antagonists, such as ketamine, or drugs that modulate presynaptic glutamate release, such as gabapentinoids (PubChem). While these interventions are effective for managing chronic pain, they are often limited by safety concerns such as sedation, ataxia, and cognitive impairment due to the ubiquitous role of glutamate in the central nervous system (NIH, 2022).

Other names
Glutamatergic signaling in the spinal dorsal hornSpinal excitatory neurotransmissionGlutamate-mediated nociceptive transmission
02

Mechanism of action

Modulation of excitatory signaling through the antagonism of postsynaptic glutamate receptors (NMDA, AMPA) or the inhibition of presynaptic glutamate release via voltage-gated calcium channel modulation.

03

Biological functions

NociceptionSensory processingSynaptic plasticitySignal transduction
04

Disease associations

Chronic painNeuropathic painHyperalgesiaAllodyniaFibromyalgia
05

Safety considerations

Dissociative effectsCognitive impairmentSedationAtaxiaMotor impairment
06

Interacting drugs

Ketamine

5 more in the full profile.

07

Biomarkers

Cerebrospinal fluid glutamate levelsQuantitative Sensory Testing (QST)Functional MRI of the spinal cord

Beyond the preview

Go deeper on Excitatory glutamatergic synaptic transmission in spinal dorsal horn.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Excitatory glutamatergic synaptic transmission in spinal dorsal horn.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call